Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
Brain disorders resulting from inborn metabolic errors, primarily from enzymatic defects which lead to substrate accumulation, product reduction, or increase in toxic metabolites through alternate pathways. The majority of these conditions are familial, however spontaneous mutation may also occur in utero.
Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.
Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase (IDURONIDASE) and characterized by progressive physical deterioration with urinary excretion of DERMATAN SULFATE and HEPARAN SULFATE. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome (formerly mucopolysaccharidosis V). Symptoms may include DWARFISM; hepatosplenomegaly; thick, coarse facial features with low nasal bridge; corneal clouding; cardiac complications; and noisy breathing.
Any of various diseases affecting the white matter of the central nervous system.
Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary (i.e., disorders intrinsic to the brain) and secondary (i.e., extracranial) metabolic conditions that adversely affect cerebral function.
Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states.
A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue.
The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.
Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.
Self-renewing cells that generate the main phenotypes of the nervous system in both the embryo and adult. Neural stem cells are precursors to both NEURONS and NEUROGLIA.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury.
A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
Imaging techniques used to colocalize sites of brain functions or physiological activity with brain structures.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
The third type of glial cell, along with astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in central nervous system development and remodeling.
A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation.
A technique of inputting two-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer.
The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING).
Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6)
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
The part of the brain that connects the CEREBRAL HEMISPHERES with the SPINAL CORD. It consists of the MESENCEPHALON; PONS; and MEDULLA OBLONGATA.
Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
A circumscribed collection of purulent exudate in the brain, due to bacterial and other infections. The majority are caused by spread of infected material from a focus of suppuration elsewhere in the body, notably the PARANASAL SINUSES, middle ear (see EAR, MIDDLE); HEART (see also ENDOCARDITIS, BACTERIAL), and LUNG. Penetrating CRANIOCEREBRAL TRAUMA and NEUROSURGICAL PROCEDURES may also be associated with this condition. Clinical manifestations include HEADACHE; SEIZURES; focal neurologic deficits; and alterations of consciousness. (Adams et al., Principles of Neurology, 6th ed, pp712-6)
A reduction in brain oxygen supply due to ANOXEMIA (a reduced amount of oxygen being carried in the blood by HEMOGLOBIN), or to a restriction of the blood supply to the brain, or both. Severe hypoxia is referred to as anoxia, and is a relatively common cause of injury to the central nervous system. Prolonged brain anoxia may lead to BRAIN DEATH or a PERSISTENT VEGETATIVE STATE. Histologically, this condition is characterized by neuronal loss which is most prominent in the HIPPOCAMPUS; GLOBUS PALLIDUS; CEREBELLUM; and inferior olives.
The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulchi. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions.
A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. (1/159)

We prospectively evaluated the neuropathological complications of 180 patients who underwent autopsy studies following bone marrow transplantation (BMT) (177 allogeneic, three autologous). The most frequent underlying disorders included severe aplastic anemia (n = 55), chronic myelogenous leukemia (n = 53), acute myelogenous leukemia (n = 24) and Fanconi anemia (n = 16). There were 114 males and 66 females. Neuropathological findings were detected in 90.55% of the patients. The most frequent findings were subarachnoid hemorrhages (SAH) (n = 57), intraparenchymal hemorrhages (IHP) (n = 49), fungal infections (n = 16), Wernicke's encephalopathy (n = 10), microglial nodular encephalopathy (n = 10) and neurotoxoplasmosis (n = 8). In only 17 patients was the brain within normal limits. Survival time after BMT averaged 5.4 months and the majority of patients died in the first 3 months post BMT (n = 105). Central nervous system (CNS) pathology was the main cause of death in 17% of the patients (n = 31), with a predominance of IHP in this particular group. Furthermore, the survival time of these patients who died of CNS causes (96.3 days) was almost half of the survival time of those who died of extra-cerebral causes (177.8 days) (P = 0.0162). IHP (70. 96 vs27.22%) (P < 0.001), fungal infections (25.8 vs 8.88%) (P < 0. 001) and toxoplasmosis (9.67 vs 4.44%) (P < 0.001) were significantly more frequent in the group of patients who died due to CNS causes than in the control group. The findings of this work provide a possible guide to the possible causes of neurological syndromes following BMT. Bone Marrow Transplantation (2000) 25, 301-307.  (+info)

Bone marrow transplantation corrects osteopetrosis in the carbonic anhydrase II deficiency syndrome. (2/159)

Carbonic anhydrase II (CAII), found in renal tubules, brain, and osteoclasts, is critical in acid-base homeostasis and bone remodeling. Deficiency of CAII gives rise to a syndrome of osteopetrosis, renal tubular acidosis (RTA), and cerebral calcification with associated developmental delay. It is inherited in an autosomal recessive fashion and found most frequently in the Mediterranean region and the Middle East. We report 2 related Irish families with clinically severe CAII deficiency in whom the gene mutation has been fully elucidated. Two children, one from each family, have undergone allogeneic bone marrow transplantation because of severe progressive visual and hearing loss. The older 2 children had already developed cerebral calcification and marked visual loss at the time of diagnosis and were treated symptomatically. Post-transplantation evaluation at 2 and 3 years demonstrates histologic and radiologic resolution of their osteopetrosis with stabilization of hearing and vision. Both children remain developmentally delayed and continue to have RTA, and the older child has now developed cerebral calcification. Allogeneic bone marrow stem cell replacement cures the osteoclast component of CAII deficiency and retards the development of cerebral calcification, but it appears to have little or no effect on the renal lesions. (Blood. 2001;97:1947-1950)  (+info)

Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure. (3/159)

BACKGROUND: Cerebral metabolic abnormalities were proposed as a potential marker of disease severity in congestive heart failure (CHF), but their prognostic significance remains uncertain. METHODS AND RESULTS: We investigated the prognostic value of cerebral metabolic abnormalities in 130 consecutive patients with advanced CHF (100 men aged 42.6+/-11.9 years; left ventricular ejection fraction, 22.2+/-6.2%). Proton magnetic resonance spectroscopy data were obtained from localized regions ( approximately 8 mL) of the occipital gray matter and the parietal white matter. The primary end point was the occurrence of death after the proton magnetic resonance spectroscopy. During follow-up (18.5+/-14.4 months), 21 patients died and 15 underwent urgent heart transplantation. In the Cox proportional model, occipital metabolites (N-acetylaspartate, creatine, choline, and myoinositol), parietal N-acetylaspartate level, and the duration of CHF symptoms (>12 months) were validated as univariate predictors of death. In multivariate Cox analyses, however, the occipital N-acetylaspartate level was an independent predictor of death (hazard ratio, 0.52; 95% CI, 0.41 to 0.67; P<0.001). An analysis with respect to the combined end point of death or urgent transplantation showed similar results. The best cutoff value (9.0 mmol/kg) for occipital N-acetylaspartate level had 75% sensitivity and 67% specificity to predict mortality. CONCLUSIONS: The occipital N-acetylaspartate level is a powerful and independent predictor of CHF mortality, suggesting that cerebral metabolic abnormalities may be used as a new prognostic marker in the assessment of patients with CHF.  (+info)

Regression of ventral striatum hypometabolism after calcium/calcitriol therapy in paroxysmal kinesigenic choreoathetosis due to idiopathic primary hypoparathyroidism. (4/159)

A [(18)F]-FDG PET study was performed in a 44 year old man with proximal kinesigenic choreoathetosis (PKC) secondary to idiopathic primary hypoparathyroidism (IPH) before and 1 year after calcium/calcitriol therapy. The [(18)F]-FDG PET performed before the start of the therapy disclosed a significant bilateral hypometabolism in the ventral striatum. One year later, with the patient still under calcium/calcitriol therapy and free of any occurrence of PKC episodes, the [(18)F]-FDG PET did not show the previously detected hypometabolism. The hypometabolism of the ventral striatum secondary to hypocalcaemia seems to play a crucial part in the pathogenesis of paroxysmal kinesigenic choreoathetosis associated with IPH.  (+info)

Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy. (5/159)

The clinical syndrome of encephalopathy is most often encountered in the context of decompensated liver disease and the diagnosis is usually clear cut. Non-hepatic causes of encephalopathy are rarer and tend to present to a wide range of medical specialties with variable and episodic symptoms. Delay can result in the development of potentially life threatening complications, such as seizures and coma. Early recognition is vital. A history of similar episodes or clinical risk factors and early assessment of blood ammonia levels help establish the diagnosis. In addition to adequate supportive care, investigation of the underlying cause of the hyperammonaemia is essential and its reversal, where possible, will often result in complete recovery. Detection of an unborn error of metabolism should lead to the initiation of appropriate maintenance therapy and genetic counselling.  (+info)

Glucose and oxygen hypometabolism in aceruloplasminemia brains. (6/159)

OBJECTIVE: Aceruloplasminemia is an iron metabolic disorder caused by mutations in the ceruloplasmin gene. It is characterized by progressive neurodegeneration in association with iron accumulation. Excess iron functions as a potent catalyst of biologic oxidation. Previously we showed that an increased iron concentration is associated with the products of lipid peroxidation in the serum, cerebrospinal fluid, and brain tissues. To clarify the free radical-mediated tissue injury caused by intracellular iron accumulation through mitochondrial dysfunction. PATIENTS AND METHODS: We have measure brain oxygen and glucose metabolisms using positron emission tomography (PET) and examined brains at autopsy for iron contents and activities of the mitochondrial respiratory chain in two affected patients who had different truncation mutations of the ceruloplasmin gene. RESULTS: PET showed a marked decrease in glucose and oxygen consumption in the entire brain of aceruloplasminemia patients, with a preponderance of metabolic reduction in basal ganglia. Enzyme activities in the mitochondrial respiratory chain of the basal ganglia were reduced to approximately 45% and 42% respectively for complexes I and IV. An inverse relationship was shown between the amounts of iron accumulated and the levels of mitochondrial enzyme activities in all the brain regions examined. CONCLUSION: Iron-mediated free radicals may contribute to the impairment of mitochondrial energy metabolism in aceruloplasminemia.  (+info)

Fat oxidation defect presenting with overwhelming ketonuria. (7/159)

Ketonuria accompanying hypoglycaemia is conventionally thought to exclude fat oxidation defects. We describe a 2 year old girl with hypoglycaemic encephalopathy in whom a diagnosis of very long chain acyl CoA dehydrogenase deficiency was suggested on the basis of acylcarnitine analysis despite massive ketonuria.  (+info)

Axonal damage: a key predictor of outcome in human CNS diseases. (8/159)

Axonal damage has recently been recognized to be a key predictor of outcome in a number of diverse human CNS diseases, including head and spinal cord trauma, metabolic encephalopathies, multiple sclerosis and other white-matter diseases (acute haemorrhagic leucoencephalitis, leucodystrophies and central pontine myelinolysis), infections [malaria, acquired immunodeficiency syndrome (AIDS) and infection with human lymphotropic virus type 1 (HTLV-I) causing HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP)] and subcortical ischaemic damage. The evidence for axonal damage and, where available, its correlation with neurological outcome in each of these conditions is reviewed. We consider the possible pathogenetic mechanisms involved and how increasing understanding of these may lead to more effective therapeutic or preventive interventions.  (+info)

Brain diseases, also known as neurological disorders, refer to a wide range of conditions that affect the brain and nervous system. These diseases can be caused by various factors such as genetics, infections, injuries, degeneration, or structural abnormalities. They can affect different parts of the brain, leading to a variety of symptoms and complications.

Some examples of brain diseases include:

1. Alzheimer's disease - a progressive degenerative disorder that affects memory and cognitive function.
2. Parkinson's disease - a movement disorder characterized by tremors, stiffness, and difficulty with coordination and balance.
3. Multiple sclerosis - a chronic autoimmune disease that affects the nervous system and can cause a range of symptoms such as vision loss, muscle weakness, and cognitive impairment.
4. Epilepsy - a neurological disorder characterized by recurrent seizures.
5. Brain tumors - abnormal growths in the brain that can be benign or malignant.
6. Stroke - a sudden interruption of blood flow to the brain, which can cause paralysis, speech difficulties, and other neurological symptoms.
7. Meningitis - an infection of the membranes surrounding the brain and spinal cord.
8. Encephalitis - an inflammation of the brain that can be caused by viruses, bacteria, or autoimmune disorders.
9. Huntington's disease - a genetic disorder that affects muscle coordination, cognitive function, and mental health.
10. Migraine - a neurological condition characterized by severe headaches, often accompanied by nausea, vomiting, and sensitivity to light and sound.

Brain diseases can range from mild to severe and may be treatable or incurable. They can affect people of all ages and backgrounds, and early diagnosis and treatment are essential for improving outcomes and quality of life.

The brain is the central organ of the nervous system, responsible for receiving and processing sensory information, regulating vital functions, and controlling behavior, movement, and cognition. It is divided into several distinct regions, each with specific functions:

1. Cerebrum: The largest part of the brain, responsible for higher cognitive functions such as thinking, learning, memory, language, and perception. It is divided into two hemispheres, each controlling the opposite side of the body.
2. Cerebellum: Located at the back of the brain, it is responsible for coordinating muscle movements, maintaining balance, and fine-tuning motor skills.
3. Brainstem: Connects the cerebrum and cerebellum to the spinal cord, controlling vital functions such as breathing, heart rate, and blood pressure. It also serves as a relay center for sensory information and motor commands between the brain and the rest of the body.
4. Diencephalon: A region that includes the thalamus (a major sensory relay station) and hypothalamus (regulates hormones, temperature, hunger, thirst, and sleep).
5. Limbic system: A group of structures involved in emotional processing, memory formation, and motivation, including the hippocampus, amygdala, and cingulate gyrus.

The brain is composed of billions of interconnected neurons that communicate through electrical and chemical signals. It is protected by the skull and surrounded by three layers of membranes called meninges, as well as cerebrospinal fluid that provides cushioning and nutrients.

Metabolic brain diseases are a group of disorders caused by genetic defects that affect the body's metabolism and result in abnormal accumulation of harmful substances in the brain. These conditions are present at birth (inborn) or develop during infancy or early childhood. Examples of metabolic brain diseases that are present at birth include:

1. Phenylketonuria (PKU): A disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, which leads to an accumulation of phenylalanine in the brain and can cause intellectual disability, seizures, and behavioral problems if left untreated.
2. Maple syrup urine disease (MSUD): A disorder caused by a deficiency of the enzyme branched-chain ketoacid dehydrogenase, which leads to an accumulation of branched-chain amino acids in the body and can cause intellectual disability, seizures, and metabolic crisis if left untreated.
3. Urea cycle disorders: A group of disorders caused by defects in enzymes that help remove ammonia from the body. Accumulation of ammonia in the blood can lead to brain damage, coma, or death if not treated promptly.
4. Organic acidemias: A group of disorders caused by defects in enzymes that help break down certain amino acids and other organic compounds. These conditions can cause metabolic acidosis, seizures, and developmental delays if left untreated.

Early diagnosis and treatment of these conditions are crucial to prevent irreversible brain damage and other complications. Treatment typically involves dietary restrictions, supplements, and medications to manage the underlying metabolic imbalance. In some cases, enzyme replacement therapy or liver transplantation may be necessary.

Encephalitis is defined as inflammation of the brain parenchyma, which is often caused by viral infections but can also be due to bacterial, fungal, or parasitic infections, autoimmune disorders, or exposure to toxins. The infection or inflammation can cause various symptoms such as headache, fever, confusion, seizures, and altered consciousness, ranging from mild symptoms to severe cases that can lead to brain damage, long-term disabilities, or even death.

The diagnosis of encephalitis typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT scans), and laboratory tests (such as cerebrospinal fluid analysis). Treatment may include antiviral medications, corticosteroids, immunoglobulins, and supportive care to manage symptoms and prevent complications.

Medical Definition:

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technique that uses a strong magnetic field and radio waves to create detailed cross-sectional or three-dimensional images of the internal structures of the body. The patient lies within a large, cylindrical magnet, and the scanner detects changes in the direction of the magnetic field caused by protons in the body. These changes are then converted into detailed images that help medical professionals to diagnose and monitor various medical conditions, such as tumors, injuries, or diseases affecting the brain, spinal cord, heart, blood vessels, joints, and other internal organs. MRI does not use radiation like computed tomography (CT) scans.

Mucopolysaccharidosis I (MPS I) is a rare genetic disorder caused by the deficiency of an enzyme called alpha-L-iduronidase. This enzyme is responsible for breaking down complex sugars called glycosaminoglycans (GAGs), also known as mucopolysaccharides, in the body.

When the enzyme is deficient, GAGs accumulate in various tissues and organs, leading to a range of symptoms that can affect different parts of the body, including the skeletal system, heart, respiratory system, eyes, and central nervous system. There are three subtypes of MPS I: Hurler syndrome (the most severe form), Hurler-Scheie syndrome (an intermediate form), and Scheie syndrome (the least severe form).

The symptoms and severity of MPS I can vary widely depending on the specific subtype, with Hurler syndrome typically causing more significant health problems and a shorter life expectancy than the other two forms. Treatment options for MPS I include enzyme replacement therapy, bone marrow transplantation, and various supportive therapies to manage symptoms and improve quality of life.

Leukoencephalopathies are a group of medical conditions that primarily affect the white matter of the brain, which consists mainly of nerve fibers covered by myelin sheaths. These conditions are characterized by abnormalities in the structure and function of the white matter, leading to various neurological symptoms such as cognitive decline, motor impairment, seizures, and behavioral changes.

The term "leukoencephalopathy" is derived from two Greek words: "leukos," meaning white, and "enkephalos," meaning brain. The suffix "-pathy" refers to a disease or suffering. Therefore, leukoencephalopathies refer specifically to diseases that affect the white matter of the brain.

There are various types of leukoencephalopathies, including genetic, metabolic, infectious, toxic, and immune-mediated forms. Some examples include multiple sclerosis, adrenoleukodystrophy, Alexander disease, Canavan disease, and Marchiafava-Bignami disease. The diagnosis of leukoencephalopathies typically involves a combination of clinical evaluation, imaging studies such as MRI, and sometimes genetic or laboratory testing to identify the underlying cause. Treatment depends on the specific type and severity of the condition and may include medications, dietary modifications, physical therapy, or supportive care.

Metabolic brain diseases refer to a group of conditions that are caused by disruptions in the body's metabolic processes, which affect the brain. These disorders can be inherited or acquired and can result from problems with the way the body produces, breaks down, or uses energy and nutrients.

Examples of metabolic brain diseases include:

1. Mitochondrial encephalomyopathies: These are a group of genetic disorders that affect the mitochondria, which are the energy-producing structures in cells. When the mitochondria don't function properly, it can lead to muscle weakness, neurological problems, and developmental delays.
2. Leukodystrophies: These are a group of genetic disorders that affect the white matter of the brain, which is made up of nerve fibers covered in myelin, a fatty substance that insulates the fibers and helps them transmit signals. When the myelin breaks down or is not produced properly, it can lead to cognitive decline, motor problems, and other neurological symptoms.
3. Lysosomal storage disorders: These are genetic disorders that affect the lysosomes, which are structures in cells that break down waste products and recycle cellular materials. When the lysosomes don't function properly, it can lead to the accumulation of waste products in cells, including brain cells, causing damage and neurological symptoms.
4. Maple syrup urine disease: This is a genetic disorder that affects the way the body breaks down certain amino acids, leading to a buildup of toxic levels of these substances in the blood and urine. If left untreated, it can cause brain damage, developmental delays, and other neurological problems.
5. Homocystinuria: This is a genetic disorder that affects the way the body processes an amino acid called methionine, leading to a buildup of homocysteine in the blood. High levels of homocysteine can cause damage to the blood vessels and lead to neurological problems, including seizures, developmental delays, and cognitive decline.

Treatment for metabolic brain diseases may involve dietary changes, supplements, medications, or other therapies aimed at managing symptoms and preventing further damage to the brain. In some cases, a stem cell transplant may be recommended as a treatment option.

Brain chemistry refers to the chemical processes that occur within the brain, particularly those involving neurotransmitters, neuromodulators, and neuropeptides. These chemicals are responsible for transmitting signals between neurons (nerve cells) in the brain, allowing for various cognitive, emotional, and physical functions.

Neurotransmitters are chemical messengers that transmit signals across the synapse (the tiny gap between two neurons). Examples of neurotransmitters include dopamine, serotonin, norepinephrine, GABA (gamma-aminobutyric acid), and glutamate. Each neurotransmitter has a specific role in brain function, such as regulating mood, motivation, attention, memory, and movement.

Neuromodulators are chemicals that modify the effects of neurotransmitters on neurons. They can enhance or inhibit the transmission of signals between neurons, thereby modulating brain activity. Examples of neuromodulators include acetylcholine, histamine, and substance P.

Neuropeptides are small protein-like molecules that act as neurotransmitters or neuromodulators. They play a role in various physiological functions, such as pain perception, stress response, and reward processing. Examples of neuropeptides include endorphins, enkephalins, and oxytocin.

Abnormalities in brain chemistry can lead to various neurological and psychiatric conditions, such as depression, anxiety disorders, schizophrenia, Parkinson's disease, and Alzheimer's disease. Understanding brain chemistry is crucial for developing effective treatments for these conditions.

Alzheimer's disease is a progressive disorder that causes brain cells to waste away (degenerate) and die. It's the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that disrupts a person's ability to function independently.

The early signs of the disease include forgetting recent events or conversations. As the disease progresses, a person with Alzheimer's disease will develop severe memory impairment and lose the ability to carry out everyday tasks.

Currently, there's no cure for Alzheimer's disease. However, treatments can temporarily slow the worsening of dementia symptoms and improve quality of life.

The Blood-Brain Barrier (BBB) is a highly specialized, selective interface between the central nervous system (CNS) and the circulating blood. It is formed by unique endothelial cells that line the brain's capillaries, along with tight junctions, astrocytic foot processes, and pericytes, which together restrict the passage of substances from the bloodstream into the CNS. This barrier serves to protect the brain from harmful agents and maintain a stable environment for proper neural function. However, it also poses a challenge in delivering therapeutics to the CNS, as most large and hydrophilic molecules cannot cross the BBB.

Neurons, also known as nerve cells or neurocytes, are specialized cells that constitute the basic unit of the nervous system. They are responsible for receiving, processing, and transmitting information and signals within the body. Neurons have three main parts: the dendrites, the cell body (soma), and the axon. The dendrites receive signals from other neurons or sensory receptors, while the axon transmits these signals to other neurons, muscles, or glands. The junction between two neurons is called a synapse, where neurotransmitters are released to transmit the signal across the gap (synaptic cleft) to the next neuron. Neurons vary in size, shape, and structure depending on their function and location within the nervous system.

A brain injury is defined as damage to the brain that occurs following an external force or trauma, such as a blow to the head, a fall, or a motor vehicle accident. Brain injuries can also result from internal conditions, such as lack of oxygen or a stroke. There are two main types of brain injuries: traumatic and acquired.

Traumatic brain injury (TBI) is caused by an external force that results in the brain moving within the skull or the skull being fractured. Mild TBIs may result in temporary symptoms such as headaches, confusion, and memory loss, while severe TBIs can cause long-term complications, including physical, cognitive, and emotional impairments.

Acquired brain injury (ABI) is any injury to the brain that occurs after birth and is not hereditary, congenital, or degenerative. ABIs are often caused by medical conditions such as strokes, tumors, anoxia (lack of oxygen), or infections.

Both TBIs and ABIs can range from mild to severe and may result in a variety of physical, cognitive, and emotional symptoms that can impact a person's ability to perform daily activities and function independently. Treatment for brain injuries typically involves a multidisciplinary approach, including medical management, rehabilitation, and supportive care.

Neural stem cells (NSCs) are a type of undifferentiated cells found in the central nervous system, including the brain and spinal cord. They have the ability to self-renew and generate the main types of cells found in the nervous system, such as neurons, astrocytes, and oligodendrocytes. NSCs are capable of dividing symmetrically to increase their own population or asymmetrically to produce one stem cell and one differentiated cell. They play a crucial role in the development and maintenance of the nervous system, and have the potential to be used in regenerative medicine and therapies for neurological disorders and injuries.

Brain neoplasms, also known as brain tumors, are abnormal growths of cells within the brain. These growths can be benign (non-cancerous) or malignant (cancerous). Benign brain tumors typically grow slowly and do not spread to other parts of the body. However, they can still cause serious problems if they press on sensitive areas of the brain. Malignant brain tumors, on the other hand, are cancerous and can grow quickly, invading surrounding brain tissue and spreading to other parts of the brain or spinal cord.

Brain neoplasms can arise from various types of cells within the brain, including glial cells (which provide support and insulation for nerve cells), neurons (nerve cells that transmit signals in the brain), and meninges (the membranes that cover the brain and spinal cord). They can also result from the spread of cancer cells from other parts of the body, known as metastatic brain tumors.

Symptoms of brain neoplasms may vary depending on their size, location, and growth rate. Common symptoms include headaches, seizures, weakness or paralysis in the limbs, difficulty with balance and coordination, changes in speech or vision, confusion, memory loss, and changes in behavior or personality.

Treatment for brain neoplasms depends on several factors, including the type, size, location, and grade of the tumor, as well as the patient's age and overall health. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these approaches. Regular follow-up care is essential to monitor for recurrence and manage any long-term effects of treatment.

Astrocytes are a type of star-shaped glial cell found in the central nervous system (CNS), including the brain and spinal cord. They play crucial roles in supporting and maintaining the health and function of neurons, which are the primary cells responsible for transmitting information in the CNS.

Some of the essential functions of astrocytes include:

1. Supporting neuronal structure and function: Astrocytes provide structural support to neurons by ensheathing them and maintaining the integrity of the blood-brain barrier, which helps regulate the entry and exit of substances into the CNS.
2. Regulating neurotransmitter levels: Astrocytes help control the levels of neurotransmitters in the synaptic cleft (the space between two neurons) by taking up excess neurotransmitters and breaking them down, thus preventing excessive or prolonged activation of neuronal receptors.
3. Providing nutrients to neurons: Astrocytes help supply energy metabolites, such as lactate, to neurons, which are essential for their survival and function.
4. Modulating synaptic activity: Through the release of various signaling molecules, astrocytes can modulate synaptic strength and plasticity, contributing to learning and memory processes.
5. Participating in immune responses: Astrocytes can respond to CNS injuries or infections by releasing pro-inflammatory cytokines and chemokines, which help recruit immune cells to the site of injury or infection.
6. Promoting neuronal survival and repair: In response to injury or disease, astrocytes can become reactive and undergo morphological changes that aid in forming a glial scar, which helps contain damage and promote tissue repair. Additionally, they release growth factors and other molecules that support the survival and regeneration of injured neurons.

Dysfunction or damage to astrocytes has been implicated in several neurological disorders, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS).

Schizophrenia is a severe mental disorder characterized by disturbances in thought, perception, emotion, and behavior. It often includes hallucinations (usually hearing voices), delusions, paranoia, and disorganized speech and behavior. The onset of symptoms typically occurs in late adolescence or early adulthood. Schizophrenia is a complex, chronic condition that requires ongoing treatment and management. It significantly impairs social and occupational functioning, and it's often associated with reduced life expectancy due to comorbid medical conditions. The exact causes of schizophrenia are not fully understood, but research suggests that genetic, environmental, and neurodevelopmental factors play a role in its development.

Brain mapping is a broad term that refers to the techniques used to understand the structure and function of the brain. It involves creating maps of the various cognitive, emotional, and behavioral processes in the brain by correlating these processes with physical locations or activities within the nervous system. Brain mapping can be accomplished through a variety of methods, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET) scans, electroencephalography (EEG), and others. These techniques allow researchers to observe which areas of the brain are active during different tasks or thoughts, helping to shed light on how the brain processes information and contributes to our experiences and behaviors. Brain mapping is an important area of research in neuroscience, with potential applications in the diagnosis and treatment of neurological and psychiatric disorders.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Microglia are a type of specialized immune cell found in the brain and spinal cord. They are part of the glial family, which provide support and protection to the neurons in the central nervous system (CNS). Microglia account for about 10-15% of all cells found in the CNS.

The primary role of microglia is to constantly survey their environment and eliminate any potentially harmful agents, such as pathogens, dead cells, or protein aggregates. They do this through a process called phagocytosis, where they engulf and digest foreign particles or cellular debris. In addition to their phagocytic function, microglia also release various cytokines, chemokines, and growth factors that help regulate the immune response in the CNS, promote neuronal survival, and contribute to synaptic plasticity.

Microglia can exist in different activation states depending on the nature of the stimuli they encounter. In a resting state, microglia have a small cell body with numerous branches that are constantly monitoring their surroundings. When activated by an injury, infection, or neurodegenerative process, microglia change their morphology and phenotype, retracting their processes and adopting an amoeboid shape to migrate towards the site of damage or inflammation. Based on the type of activation, microglia can release both pro-inflammatory and anti-inflammatory factors that contribute to either neuroprotection or neurotoxicity.

Dysregulation of microglial function has been implicated in several neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and Amyotrophic Lateral Sclerosis (ALS). Therefore, understanding the role of microglia in health and disease is crucial for developing novel therapeutic strategies to treat these conditions.

The hippocampus is a complex, curved formation in the brain that resembles a seahorse (hence its name, from the Greek word "hippos" meaning horse and "kampos" meaning sea monster). It's part of the limbic system and plays crucial roles in the formation of memories, particularly long-term ones.

This region is involved in spatial navigation and cognitive maps, allowing us to recognize locations and remember how to get to them. Additionally, it's one of the first areas affected by Alzheimer's disease, which often results in memory loss as an early symptom.

Anatomically, it consists of two main parts: the Ammon's horn (or cornu ammonis) and the dentate gyrus. These structures are made up of distinct types of neurons that contribute to different aspects of learning and memory.

Computer-assisted image processing is a medical term that refers to the use of computer systems and specialized software to improve, analyze, and interpret medical images obtained through various imaging techniques such as X-ray, CT (computed tomography), MRI (magnetic resonance imaging), ultrasound, and others.

The process typically involves several steps, including image acquisition, enhancement, segmentation, restoration, and analysis. Image processing algorithms can be used to enhance the quality of medical images by adjusting contrast, brightness, and sharpness, as well as removing noise and artifacts that may interfere with accurate diagnosis. Segmentation techniques can be used to isolate specific regions or structures of interest within an image, allowing for more detailed analysis.

Computer-assisted image processing has numerous applications in medical imaging, including detection and characterization of lesions, tumors, and other abnormalities; assessment of organ function and morphology; and guidance of interventional procedures such as biopsies and surgeries. By automating and standardizing image analysis tasks, computer-assisted image processing can help to improve diagnostic accuracy, efficiency, and consistency, while reducing the potential for human error.

Aging is a complex, progressive and inevitable process of bodily changes over time, characterized by the accumulation of cellular damage and degenerative changes that eventually lead to increased vulnerability to disease and death. It involves various biological, genetic, environmental, and lifestyle factors that contribute to the decline in physical and mental functions. The medical field studies aging through the discipline of gerontology, which aims to understand the underlying mechanisms of aging and develop interventions to promote healthy aging and extend the human healthspan.

A mental disorder is a syndrome characterized by clinically significant disturbance in an individual's cognition, emotion regulation, or behavior. It's associated with distress and/or impaired functioning in social, occupational, or other important areas of life, often leading to a decrease in quality of life. These disorders are typically persistent and can be severe and disabling. They may be related to factors such as genetics, early childhood experiences, or trauma. Examples include depression, anxiety disorders, bipolar disorder, schizophrenia, and personality disorders. It's important to note that a diagnosis should be made by a qualified mental health professional.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.

Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.

These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.

Magnetic Resonance Spectroscopy (MRS) is a non-invasive diagnostic technique that provides information about the biochemical composition of tissues, including their metabolic state. It is often used in conjunction with Magnetic Resonance Imaging (MRI) to analyze various metabolites within body tissues, such as the brain, heart, liver, and muscles.

During MRS, a strong magnetic field, radio waves, and a computer are used to produce detailed images and data about the concentration of specific metabolites in the targeted tissue or organ. This technique can help detect abnormalities related to energy metabolism, neurotransmitter levels, pH balance, and other biochemical processes, which can be useful for diagnosing and monitoring various medical conditions, including cancer, neurological disorders, and metabolic diseases.

There are different types of MRS, such as Proton (^1^H) MRS, Phosphorus-31 (^31^P) MRS, and Carbon-13 (^13^C) MRS, each focusing on specific elements or metabolites within the body. The choice of MRS technique depends on the clinical question being addressed and the type of information needed for diagnosis or monitoring purposes.

Brain edema is a medical condition characterized by the abnormal accumulation of fluid in the brain, leading to an increase in intracranial pressure. This can result from various causes, such as traumatic brain injury, stroke, infection, brain tumors, or inflammation. The swelling of the brain can compress vital structures, impair blood flow, and cause neurological symptoms, which may range from mild headaches to severe cognitive impairment, seizures, coma, or even death if not treated promptly and effectively.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

A biological marker, often referred to as a biomarker, is a measurable indicator that reflects the presence or severity of a disease state, or a response to a therapeutic intervention. Biomarkers can be found in various materials such as blood, tissues, or bodily fluids, and they can take many forms, including molecular, histologic, radiographic, or physiological measurements.

In the context of medical research and clinical practice, biomarkers are used for a variety of purposes, such as:

1. Diagnosis: Biomarkers can help diagnose a disease by indicating the presence or absence of a particular condition. For example, prostate-specific antigen (PSA) is a biomarker used to detect prostate cancer.
2. Monitoring: Biomarkers can be used to monitor the progression or regression of a disease over time. For instance, hemoglobin A1c (HbA1c) levels are monitored in diabetes patients to assess long-term blood glucose control.
3. Predicting: Biomarkers can help predict the likelihood of developing a particular disease or the risk of a negative outcome. For example, the presence of certain genetic mutations can indicate an increased risk for breast cancer.
4. Response to treatment: Biomarkers can be used to evaluate the effectiveness of a specific treatment by measuring changes in the biomarker levels before and after the intervention. This is particularly useful in personalized medicine, where treatments are tailored to individual patients based on their unique biomarker profiles.

It's important to note that for a biomarker to be considered clinically valid and useful, it must undergo rigorous validation through well-designed studies, including demonstrating sensitivity, specificity, reproducibility, and clinical relevance.

The brainstem is the lower part of the brain that connects to the spinal cord. It consists of the midbrain, pons, and medulla oblongata. The brainstem controls many vital functions such as heart rate, breathing, and blood pressure. It also serves as a relay center for sensory and motor information between the cerebral cortex and the rest of the body. Additionally, several cranial nerves originate from the brainstem, including those that control eye movements, facial movements, and hearing.

Brain ischemia is the medical term used to describe a reduction or interruption of blood flow to the brain, leading to a lack of oxygen and glucose delivery to brain tissue. This can result in brain damage or death of brain cells, known as infarction. Brain ischemia can be caused by various conditions such as thrombosis (blood clot formation), embolism (obstruction of a blood vessel by a foreign material), or hypoperfusion (reduced blood flow). The severity and duration of the ischemia determine the extent of brain damage. Symptoms can range from mild, such as transient ischemic attacks (TIAs or "mini-strokes"), to severe, including paralysis, speech difficulties, loss of consciousness, and even death. Immediate medical attention is required for proper diagnosis and treatment to prevent further damage and potential long-term complications.

A brain abscess is a localized collection of pus in the brain that is caused by an infection. It can develop as a result of a bacterial, fungal, or parasitic infection that spreads to the brain from another part of the body or from an infection that starts in the brain itself (such as from a head injury or surgery).

The symptoms of a brain abscess may include headache, fever, confusion, seizures, weakness or numbness on one side of the body, and changes in vision, speech, or behavior. Treatment typically involves antibiotics to treat the infection, as well as surgical drainage of the abscess to relieve pressure on the brain.

It is a serious medical condition that requires prompt diagnosis and treatment to prevent potentially life-threatening complications such as brain herniation or permanent neurological damage.

Brain hypoxia is a medical condition characterized by a reduced supply of oxygen to the brain. The brain requires a continuous supply of oxygen to function properly, and even a brief period of hypoxia can cause significant damage to brain cells.

Hypoxia can result from various conditions, such as cardiac arrest, respiratory failure, carbon monoxide poisoning, or high altitude exposure. When the brain is deprived of oxygen, it can lead to a range of symptoms, including confusion, disorientation, seizures, loss of consciousness, and ultimately, brain death.

Brain hypoxia is a medical emergency that requires immediate treatment to prevent long-term neurological damage or death. Treatment typically involves addressing the underlying cause of hypoxia, such as administering oxygen therapy, resuscitating the heart, or treating respiratory failure. In some cases, more invasive treatments, such as therapeutic hypothermia or mechanical ventilation, may be necessary to prevent further brain damage.

The cerebral cortex is the outermost layer of the brain, characterized by its intricate folded structure and wrinkled appearance. It is a region of great importance as it plays a key role in higher cognitive functions such as perception, consciousness, thought, memory, language, and attention. The cerebral cortex is divided into two hemispheres, each containing four lobes: the frontal, parietal, temporal, and occipital lobes. These areas are responsible for different functions, with some regions specializing in sensory processing while others are involved in motor control or associative functions. The cerebral cortex is composed of gray matter, which contains neuronal cell bodies, and is covered by a layer of white matter that consists mainly of myelinated nerve fibers.

Chronic brain damage is a condition characterized by long-term, persistent injury to the brain that results in cognitive, physical, and behavioral impairments. It can be caused by various factors such as trauma, hypoxia (lack of oxygen), infection, toxic exposure, or degenerative diseases. The effects of chronic brain damage may not be immediately apparent and can worsen over time, leading to significant disability and reduced quality of life.

The symptoms of chronic brain damage can vary widely depending on the severity and location of the injury. They may include:

* Cognitive impairments such as memory loss, difficulty concentrating, trouble with problem-solving and decision-making, and decreased learning ability
* Motor impairments such as weakness, tremors, poor coordination, and balance problems
* Sensory impairments such as hearing or vision loss, numbness, tingling, or altered sense of touch
* Speech and language difficulties such as aphasia (problems with understanding or producing speech) or dysarthria (slurred or slow speech)
* Behavioral changes such as irritability, mood swings, depression, anxiety, and personality changes

Chronic brain damage can be diagnosed through a combination of medical history, physical examination, neurological evaluation, and imaging studies such as MRI or CT scans. Treatment typically focuses on managing symptoms and maximizing function through rehabilitation therapies such as occupational therapy, speech therapy, and physical therapy. In some cases, medication or surgery may be necessary to address specific symptoms or underlying causes of the brain damage.

... is a quarterly peer-reviewed medical journal covering the study of metabolic brain diseases. It was ... "Metabolic Brain Disease". 2021 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2022. Official website v t e ...
Metabolic Brain Disease. 4 (3): 169-76. doi:10.1007/bf01000293. PMID 2796871. S2CID 24524207. Bergeron, M; Swain, MS; Reader, ... Metabolic Brain Disease. 17 (4): 463-75. doi:10.1023/A:1021986624600. PMID 12602522. S2CID 19491464. Butterworth, RF (2003). " ... severe metabolic alterations, and cerebral edema that can lead to brain death. In these cases the mortality without liver ... pathophysiology and treatment of these diseases Evaluate the clinical impact of MARS therapy on the course of the disease in ...
Metabolic Brain Disease. 37 (1): 197-207. doi:10.1007/s11011-021-00857-7. ISSN 0885-7490. PMID 34757579. S2CID 243939724. ... Aug 2013). "Probiotics for the treatment of Clostridium difficile associated disease". World J Gastrointest Pathophysiol. 4 (3 ...
Metabolic Brain Disease. 28 (2): 151-4. doi:10.1007/s11011-012-9337-3. PMID 23010935. S2CID 11206990. Ortez, C; Jou, C; Cortès- ... doi:10.1093/brain/aws038. ISSN 1460-2156. PMC 3326257. PMID 22396397. Hauser, Robert A (July 6, 2016). "Parkinson Disease ... doi:10.1093/brain/aws038. PMC 3326257. PMID 22396397. Kolb, B. Whishaw, I. (2011) An Introduction to Brain and Behavior, 592. ... "Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease". Experimental Neurology. 239: 60-7. ...
Metabolic Brain Disease. 26 (1): 79-85. doi:10.1007/s11011-011-9237-y. PMID 21327546. S2CID 19377135. Robson, D; Welch, E; ... is a disease or category of diseases that commonly causes disability and increases mortality. The causes of TAN are not ... The disease affects poor tropical populations; there are no good statistics on how many people are affected worldwide, but in ... It is possible that there are several diseases being categorized as TAN. It has been estimated that 5% of surviving World War ...
"Brain Behaviour Initiative". Metabolic Brain Disease. 21 (2-3): 279-284. doi:10.1007/s11011-006-9024-3. PMID 16850254. S2CID ... Brain imaging has played a key role in shedding light on mental disorders. However, much of this work has been based on small ... Urbach-Wiethe disease (UWD) is a rare genetic disorder characterized by early damage to the basolateral amygdala. Perhaps more ... Stein was the Director of UCT's early Brain and Behaviour Initiative, and was the inaugural Scientific Director of UCT's later ...
Jordaan GP, Emsley R (June 2014). "Alcohol-induced psychotic disorder: a review". Metabolic Brain Disease. 29 (2): 231-243. doi ... "diseases of the mind". Hippocrates writes: Men ought to know that from the brain, and from the brain only, arise our pleasures ... and Parkinson's disease focal neurological disease, such as stroke, brain tumors, multiple sclerosis, and some forms of ... Mashour GA, Walker EE, Martuza RL (June 2005). "Psychosurgery: past, present, and future". Brain Research. Brain Research ...
... transport and brain disposition". Metabolic Brain Disease. 27 (1): 1-5. doi:10.1007/s11011-011-9274-6. PMC 3276770. PMID ...
Metabolic Brain Disease. 17 (4): 375-387. doi:10.1023/a:1021970120965. ISSN 0885-7490. PMID 12602514. S2CID 23679769. Furrow, S ...
Metabolic Brain Disease. 23 (1): 115-22. doi:10.1007/s11011-007-9076-z. PMID 18034292. S2CID 9020059. Watson, A. J. S.; Walker ... Metabolic Brain Disease. 10 (1): 17-24. doi:10.1007/BF01991779. PMID 7596325. S2CID 9751459. (Wikipedia articles needing page ... Metabolic Brain Disease. 14 (1): 1-20. doi:10.1023/A:1020653312697. PMID 10348310. S2CID 19954743. Navarro, Darren; Zwingmann, ... Brain atrophy associated with WKS occurs in the following regions of the brain: the mammillary bodies, the thalamus, the ...
December 2011). "Decreased expression of myelin gene regulatory factor in Niemann-Pick type C 1 mouse". Metabolic Brain Disease ... 2020). "Acetyl-leucine slows disease progression in lysosomal storage disorders". Brain Communications. 3 (1): fcaa148. doi: ... "eMedicine - Niemann-Pick Disease : Article by Robert A Schwartz". Retrieved 2008-10-27. "Niemann-Pick Disease". Retrieved 2008- ... November 2008). "Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium". ...
Metabolic Brain Disease. 24 (2): 271-82. doi:10.1007/s11011-009-9136-7. PMID 19296210. S2CID 13460935. Department of Health and ... It is a precursor to GABA, glutamate, and glycine in certain brain areas. It acts on the GHB receptor and is a weak agonist at ... Both of the metabolic breakdown pathways shown for GHB can run in either direction, depending on the concentrations of the ... GHB-induced stimulation of tissue serotonin turnover may be due to an increase in tryptophan transport to the brain and in its ...
Metabolic Brain Disease. 31 (3): 631-641. doi:10.1007/s11011-016-9794-1. ISSN 0885-7490. PMC 4863909. PMID 26821073. Al Zarouni ... Kennedy, David O. (2014). "The Deliriants - The Nightshade (Solanaceae) Family". Plants and the Human Brain. New York: Oxford ... which can cause brain damage, other organ damage, central nervous system damage and death in sheep. Arundo donax, 0.0057% DMT ... Molecular Brain Research. 138 (2): 191-197. doi:10.1016/j.molbrainres.2005.04.009. PMC 5805132. PMID 15921820. Khanavi, M.; ...
December 2011). "Decreased expression of myelin gene regulatory factor in Niemann-Pick type C 1 mouse". Metabolic Brain Disease ... Vanier MT, Suzuki K (January 1998). "Recent advances in elucidating Niemann-Pick C disease". Brain Pathology. 8 (1): 163-74. ... One of the lesser known gene diseases that is known to be linked to obesity is the NPC1 disease, which is otherwise known as ... NPC1 disease is an autosomal-recessive lipid storage disease. It is mostly known for cholesterol infiltration, which in turn ...
Metabolic Brain Disease. 31 (4): 727-735. doi:10.1007/s11011-016-9815-0. ISSN 0885-7490. PMID 26956130. S2CID 2740172. Lintas, ... Rett syndrome brain samples and autism brain samples show immaturity of dendrite spines and reduction of cell-body size due to ... Furthermore, a significant decrease in abundance of GABRB3 has been reported in the brains of patients with autism and Rett ... Skuse, D. H. (2000). "Imprinting, the X-chromosome, and the male brain: explaining sex differences in the liability to autism ...
Metabolic Brain Disease. 29 (2): 351-7. doi:10.1007/s11011-014-9496-5. PMID 24532047. S2CID 14880172. Roy-Byrne PP, Craske MG, ... Current research also supports this perspective as it has been found that those with panic disorder also have a brain circuit ... "FASTSTATS - Illegal Drug Use". Centers for Disease Control and Prevention. 30 May 2013. Archived from the original on 5 July ... The reason chronic alcohol misuse worsens panic disorder is due to distortion of the brain chemistry and function. ...
Metabolic Brain Disease. 24 (1): 27-53. doi:10.1007/s11011-008-9118-1. hdl:11577/2380064. PMID 19085093. S2CID 4564675. ... Centers for Disease Control and Prevention. Archived from the original on 4 February 2016. Retrieved 4 February 2016. ... Placebos have been found to modify the activity of several brain regions and to increase levels of dopamine and endogenous ... Winberg S, Carter CG, McCarthy JD, He XY, Nilsson GE, Houlihan DF (1993). "Feeding rank and brain serotonergic activity in ...
"Blood-brain barrier dysfunction following traumatic brain injury". Metabolic Brain Disease. 30 (5): 1093-1104. doi:10.1007/ ... The blood-brain barrier is formed by the brain capillary endothelium and excludes from the brain 100% of large-molecule ... The blood-brain barrier may become damaged in select neurological diseases, as indicated by neuroimaging studies of Alzheimer's ... Infections of the brain that do occur are often difficult to treat. Antibodies are too large to cross the blood-brain barrier, ...
Metabolic Brain Disease. 31 (1): 205-212. doi:10.1007/s11011-015-9681-1. PMID 25987537. S2CID 3234882. Dean, Shannon L.; Singer ... Huntington's disease, Wilson disease, hyperthyroidism, lupus erythematosus, pregnancy (chorea gravidarum), drug intoxication ... causing a variety of streptococcal related diseases including Sydenham's chorea but also rheumatic heart disease and nephritic ... biotin-thiamine-responsive basal ganglia disease (BTBGD), Fahr disease, familial dyskinesia-facial myokymia (Bird-Raskind ...
Metabolic Brain Disease. 24 (1): 95-102. doi:10.1007/s11011-008-9112-7. hdl:1866/9593. ISSN 0885-7490. PMID 19104924. S2CID ... Sleep inversion is a feature of African trypanosomiasis, after which the disease takes its common name, "African sleeping ... Bosoi, Cristina R.; Rose, Christopher F. (March 2009). "Identifying the direct effects of ammonia on the brain". ... Disease". www.cdc.gov. 2020-04-28. Retrieved 2020-08-11. Maxfield, Luke; Bermudez, Rene (2020), "Trypanosomiasis ( ...
Metabolic Brain Disease. 30 (5): 1279-84. doi:10.1007/s11011-015-9672-2. PMID 25920484. S2CID 11375978. Belmont JW (June 1996 ... An extreme case of this was seen where monozygotic female twins had extreme variance in expression of Menkes disease (an X- ... For example, a female heterozygous for haemophilia (an X-linked disease) would have about half of her liver cells functioning ... Puck JM, Willard HF (January 1998). "X inactivation in females with X-linked disease". The New England Journal of Medicine. 338 ...
Metabolic Brain Disease. 31 (3): 631-641. doi:10.1007/s11011-016-9794-1. ISSN 0885-7490. PMC 4863909. PMID 26821073. Díaz, J. L ...
Metabolic Brain Disease. 26 (4): 299-306. doi:10.1007/s11011-011-9263-9. PMID 21938520. S2CID 26878522. Koenning, M.; Jackson, ... Type C is the most common form of the disease Type C2 is a rare form of the disease. Niemann-Pick disease type D (or Nova ... Lysosomal storage disease Niemann-Pick disease, type C Gaucher's disease Medical genetics of Ashkenazi Jews "Niemann-Pick". ... Niemann-Pick disease is a group of severe inherited metabolic disorders, in which sphingomyelin accumulates in lysosomes in ...
Metabolic Brain Disease. 10 (1): 17-24. doi:10.1007/BF01991779. PMID 7596325. S2CID 9751459. Zarranz JJ (2007). Neurologia (in ... Metabolic Brain Disease. 13 (2): 97-122. doi:10.1023/A:1020657129593. PMID 9699919. S2CID 25130884. Kohnke, Sara; Meek, Claire ... The blood-brain barrier junctions are typically found to have WE lesions located at that region of the brain. An altered blood- ... Powell SZ, Schochet Jr SS (March 2003). "Intoxications and Metabolic Diseases of the Central Nervous System". In Nelson JS, ...
Metabolic Brain Disease. 17 (4): 375-87. doi:10.1023/A:1021970120965. PMID 12602514. S2CID 23679769. Cersosimo, M. G.; Koller, ... It is found mostly in the bones, but also the liver, kidneys, and brain. In the human brain, the manganese is bound to ... Takeda, A. (2003). "Manganese action in brain function". Brain Research Reviews. 41 (1): 79-87. doi:10.1016/S0165-0173(02)00234 ... Unlike Parkinson's disease, manganism is not associated with loss of the sense of smell and patients are typically unresponsive ...
Metabolic Brain Disease. 24 (1): 27-53. doi:10.1007/s11011-008-9118-1. hdl:11577/2380064. PMID 19085093. S2CID 4564675. ... Manev H, Uz T, Smalheiser NR, Manev R (January 2001). "Antidepressants alter cell proliferation in the adult brain in vivo and ... At this time, decreased serotonin levels in the brain and symptoms of depression have not been linked Although there is ... Studies also show that the chronic secretion of stress hormones as a result of disease, including somatic infections or ...
Metabolic Brain Disease. 4 (1): 61-65. doi:10.1007/BF00999495. PMID 2704347. S2CID 12032912. Dictionary of Biological ... The area postrema also has a significant role in the discussion of Parkinson's disease. Drugs that treat Parkinson's disease ... "Purinergic modulation of area postrema neuronal excitability in rat brain slices". Brain Research. 1165: 50-59. doi:10.1016/j. ... In 1896, he published a two-volume monograph on the gross anatomy of the human brain in which the area postrema was mentioned.[ ...
Metabolic Brain Disease. 22 (3-4): 337-352. doi:10.1007/s11011-007-9064-3. PMID 17712616. S2CID 5823156. Stone TW (April 2001 ... Hypertryptophanemia is a rare autosomal recessive metabolic disorder that results in a massive buildup of the amino acid ... As the main defect behind hypertryptophanemia is suspected to alter and disrupt the metabolic pathway from tryptophan to ... Stone TW, Mackay GM, Forrest CM, Clark CJ, Darlington LG (July 2003). "Tryptophan metabolites and brain disorders". Clinical ...
Metabolic Brain Disease. 29 (1): 121-30. doi:10.1007/s11011-014-9480-0. PMID 24435938. S2CID 10955351. Piroli GG, Grillo CA, ... Adipose tissue, commonly known as fat, is a depository for energy in order to conserve metabolic homeostasis. As the body takes ... Sonksen P, Sonksen J (July 2000). "Insulin: understanding its action in health and disease". British Journal of Anaesthesia. 85 ... Moreover, impairment in insulin-stimulated trafficking of GLUT4 in the hippocampus result in decreased metabolic activities and ...
Metabolic Brain Disease [serial online]. September 2014;29(3):813-824. Diagram (Webarchive template wayback links, Articles ... Unilateral asterixis may occur with structural brain disease. It can be a sign of hepatic encephalopathy, damage to brain cells ... With a metabolic encephalopathy, the patient is unable to hold their hands back resulting in a "flapping" motion consistent ... It can also be a feature of Wilson's disease. Asterixis is also seen in respiratory failure due to carbon dioxide toxicity ( ...
  • In this review, we provide information about the associations of physical activity (PA) with major age-related neurodegenerative diseases and syndromes, including Alzheimer's disease, vascular dementia, and mild cognitive impairment. (mdpi.com)
  • Connections in the brain's default mode network (DMN) begin to falter years before the onset of clinical symptoms in both sporadic and familial Alzheimer's disease (AD), according to two new papers. (alzforum.org)
  • To fill this gap, the WashU group looked at data from 207 cognitively normal older adults with an average age of 70 who were participating in aging and memory studies at the Knight Alzheimer's Disease Research Center. (alzforum.org)
  • An existing epilepsy drug reverses a condition in elderly patients who are at high risk for dementia due to Alzheimer's disease. (sciencedaily.com)
  • The drug, commonly used to treat epilepsy, calms hyperactivity in the brain of patients with amnestic mild cognitive impairment (aMCI), a clinically recognized condition in which memory impairment is greater than expected for a person's age and which greatly increases risk for Alzheimer's dementia, according to the study published this week in NeuroImage: Clinical . (sciencedaily.com)
  • Mitochondrial dysfunction is one of the major intracellular lesions of Alzheimer's disease (AD). (jneurosci.org)
  • A compound found in milk can mitigate damage to people's brains caused by stroke or diseases such as Alzheimer's. (sciencenews.org)
  • A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. (neurotree.org)
  • Plaques in the brain, a signature of Alzheimer's, appear related to metabolic problems involving glucose. (thedoctorwillseeyounow.com)
  • Most of us know at least one person affected by Alzheimer's Disease , an irreversible and progressive brain disorder that slowly destroys memories and thinking skills. (thedoctorwillseeyounow.com)
  • A Brigham Young University study may signal a turn in thinking and a different road to treatment - metabolic dysfunction as a key to developing Alzheimer's. (thedoctorwillseeyounow.com)
  • Alzheimer's Disease is increasingly being referred to as insulin resistance of the brain or Type 3 Diabetes. (thedoctorwillseeyounow.com)
  • The same may be true for the connection between metabolic dysfunction of the brain and Alzheimer's. (thedoctorwillseeyounow.com)
  • As the study's senior author, Benjamin Bikman, a professor of physiology and developmental biology at Brigham Young, remarks: "Alzheimer's Disease is increasingly being referred to as insulin resistance of the brain or Type 3 Diabetes. (thedoctorwillseeyounow.com)
  • The scientists examined 240 brains post-mortem for RNA cellular sequences impacted by Alzheimer's. (thedoctorwillseeyounow.com)
  • This isn't the first time that researchers have made the connection between glucose, ketones and Alzheimer's Disease, but it is the first time it's been shown to happen on a cellular level. (thedoctorwillseeyounow.com)
  • Researchers from the department of Traditional Chinese Medicine (TCM) at the Third Xiangya Hospital in Changsha China recently conducting a study exploring the effects of an herbal extract on alzheimer's disease. (yinyanghouse.com)
  • This has caused scientists to seek other explanations for Alzheimer's, such as inflammation, immune system dysfunction, and metabolic dysfunction. (bigthink.com)
  • The causes of Alzheimer's Disease are complex and mysterious. (bigthink.com)
  • Alzheimer's is characterized by the build-up of plaques and tangles, consisting of insoluble amyloid and tau proteins, respectively, in the brain tissue, and for decades it was widely believed that plaques are the culprit. (bigthink.com)
  • The discovery in 2018 that tau protein activates jumping genes in the human brain raised interest in the idea that DNA transposition may contribute to Alzheimer's. (bigthink.com)
  • For example, retrovirus-type jumping genes are more abundant in postmortem human brain tissue obtained from Alzheimer's disease patients than in tissue from healthy controls, and these same jumping genes promote nerve cell death in fruit flies. (bigthink.com)
  • These and other findings have led researchers to propose a preliminary model of how jumping genes might contribute to Alzheimer's Disease . (bigthink.com)
  • Future work could provide important insights into the mechanisms of neurodegeneration in Alzheimer's and other diseases. (bigthink.com)
  • For over three decades, toxic proteins were believed to cause Alzheimer's disease. (bigthink.com)
  • With some of these disorders, if treated early, brain dysfunction can be reversed. (medlineplus.gov)
  • Metabolic disorders may cause confusion and changes in thinking or reasoning. (medlineplus.gov)
  • To rule out certain brain disorders, an EEG (electroencephalogram), head CT scan , or head MRI scan is usually done. (medlineplus.gov)
  • With some metabolic disorders, treatment may stop or even reverse the dementia symptoms. (medlineplus.gov)
  • Medicines used to treat Alzheimer disease have not been shown to work for these types of disorders. (medlineplus.gov)
  • Until the genes and their mutations that underlie neurological disease are characterized, inherited disorders have to be defined the way clinicians have been classifying disease over the last 2 centuries. (medscape.com)
  • AMS describes disorders or symptoms that suggest the brain isn't working properly. (webmd.com)
  • Genetic brain disorders affect the development and function of the brain. (medlineplus.gov)
  • Some genetic brain disorders are due to random gene mutations or mutations caused by environmental exposure, such as cigarette smoke. (medlineplus.gov)
  • Many people with genetic brain disorders fail to produce enough of certain proteins that influence brain development and function. (medlineplus.gov)
  • These brain disorders can cause serious problems that affect the nervous system. (medlineplus.gov)
  • A wide variety of diseases and disorders occur in the large intestine. (britannica.com)
  • It may be related to neurological disorders such as paraplegia , to unrecognized rectal strictures, and to some metabolic disorders. (britannica.com)
  • neurodevelopmental, metabolic and neuromuscular disorders. (nih.gov)
  • Ethylmalonic encephalopathy (EE) is a rare, recently defined inborn error of metabolism which affects the brain, gastrointestinal system and peripheral blood vessels and is characterized by a unique constellation of clinical and biochemical features. (nih.gov)
  • Metabolic dysfunction is involved in modulating the disease process in Huntington disease (HD) but the underlying mechanisms are not known. (lu.se)
  • Neurovascular dysfunction, including blood-brain barrier (BBB) breakdown and cerebral blood flow (CBF) dysregulation and reduction, is increasingly recognized as contributing to Alzheimer disease. (medscape.com)
  • Type 2 diabetes is an example of a disease caused by metabolic dysfunction . (thedoctorwillseeyounow.com)
  • These failures have led researchers to investigate other possible causes, including inflammation , immune system dysfunction , and metabolic dysfunction . (bigthink.com)
  • Exposure to ethanol during neurodevelopment modifies crucial offspring rat brain enzyme activities in a region-specific manner. (gla.ac.uk)
  • Quantitative real-time polymerase chain reactions were used to assess levels of SIRT1-3 and downstream targets in post mortem brain tissue from HD patients and control cases as well as after selective hypothalamic expression of mutant huntingtin (HTT) using recombinant adeno-associated viral vectors in mice. (lu.se)
  • We show that mRNA levels of the metabolic regulator SIRT1 are increased in the striatum and the cerebral cortex but not in the less affected cerebellum in post mortem HD brains. (lu.se)
  • Infertility, maternal metabolic and inflammatory variables, and offspring epigenetic alterations are prenatal risk factors. (news-medical.net)
  • Mechanisms underlying metabolic alterations in Huntington's disease. (lu.se)
  • In a butanol threshold test, de novo PD-related brain metabolic patterns were associated with olfaction ( P =.018) among patients with isolated RBD but not in patients with de novo PD and prolonged RBD ( P =.21). (neurologyadvisor.com)
  • Indeed, an increased oxidative stress was observed in the brains of ASD patients 18 . (nature.com)
  • A variety of imaging modalities, including structural and functional magnetic resonance imaging (MRI) and positron emission tomography (PET) studies of cerebral metabolism, have shown characteristic changes in the brain of patients with Alzheimer disease in prodromal and even presymptomatic states. (medscape.com)
  • Our aim was to measure the CBF, oxygen extraction fraction, and cerebral metabolic rate of oxygen use in patients with different severities of middle cerebral artery stenosis or acute stroke by using the arterial spin-labeling and susceptibility-weighted imaging techniques. (ajnr.org)
  • Patients with the classic disease also develop persistent and severe self-injurious behavior. (medscape.com)
  • In addition to the classic clinical disease, patients with less severe disease and partial syndromes are increasingly recognized. (medscape.com)
  • Methods FDG-PET was performed on a cohort of 79 patients with newly diagnosed PD (mean disease duration 8 months) and 20 unrelated controls. (bmj.com)
  • Severe neuronal loss, associated with gliosis and neurofibrillary tangles were reported in the superior colliculi of patients with PSP in the initial clinico-neuropathological description of the disease by Steele, Richardson and Olszewski. (omicsonline.org)
  • In CSF, in patients without central nervous system (CNS) disease/infection, cytokines/chemokines are either undetectable (e.g., interleukin-6 [IL-6], CXCL8/IL-8, CXCL10/IP-10, CXCL9/MIG) or present at low levels (e.g. (cdc.gov)
  • The Hope Network , a nonprofit service provider for people with brain and spinal cord injuries, reports that elderly patients (age 65 and older) are at greater risk for hospitalization and death after sustaining a TBI. (asbmb.org)
  • Dr. Yee's previous research focused on neurologic prognostication in patients with critical brain disease. (osteopathic.org)
  • Around 30-40% of patients with Crohn's disease develop perianal fistulas - an inflamed tunnel between the skin and the inside of the anus. (materialstoday.com)
  • A large number of patients are diagnosed with Crohn's disease in their late teens to early 20s, and they are contemplating a lifetime of suffering from perianal fistulas," says Florin Selaru, associate professor of medicine and oncology, director of the IBD Center at Hopkins and professor in IBD research at Johns Hopkins Medicine, and one of the senior authors of the paper. (materialstoday.com)
  • Researchers discovered glucose metabolism was impaired in the brains of deceased Alzheimer patients. (thedoctorwillseeyounow.com)
  • Clinicians are reminded to treat suspected influenza in high-risk outpatients, those with progressive disease, and all hospitalized patients with antiviral medications as soon as possible, regardless of negative rapid influenza diagnostic test (RIDT) results and without waiting for RT-PCR testing results. (cdc.gov)
  • We show that SIRT1 expression is increased in HD-affected brain regions and that metabolic pathways are altered in the HD hypothalamus. (lu.se)
  • Purine metabolic pathways. (medscape.com)
  • This prospective cohort study assessed whether PD-related brain metabolic patterns may be used as biomarkers in isolated REM sleep behavior disorder. (neurologyadvisor.com)
  • NCT02984137 ) to determine whether PD-related brain metabolic patterns may be used as biomarkers in isolated RBD and to compare metabolic patterns derived from long-stand and de novo PD. (neurologyadvisor.com)
  • Thus there is a need to better elucidate the ASD etiology and find biomarkers for early diagnosis and subsequently develop disease-modifying treatment for ASD. (nature.com)
  • However, these studies did not relate brain connectivity to fluid biomarkers, which are among the most commonly used preclinical markers. (alzforum.org)
  • Neuroimaging is widely believed to be generally useful for excluding reversible causes of dementia syndrome such as normal-pressure hydrocephalus, brain tumor, and subdural hematoma, and for excluding other likely causes of dementia such as cerebrovascular disease. (medscape.com)
  • The [de novo PD-related brain metabolic patterns] can be an efficient biomarker individually applicable in [isolated REM sleep behavior disorder]," the study authors wrote. (neurologyadvisor.com)
  • An inherited metabolic disorder that is characterized by impaired synthesis and degradation of amino acids. (mcw.edu)
  • Alzheimer disease is a progressive neurodegenerative disorder characterized by gradual onset of dementia . (medscape.com)
  • A genetic brain disorder is caused by a variation or a mutation in a gene. (medlineplus.gov)
  • Lesch-Nyhan disease is a genetic disorder associated with 3 major clinical elements: overproduction of uric acid, neurologic disability, and behavioral problems. (medscape.com)
  • Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting over four million people above the age of 50, with the prevalence expected to double to 9.3 million by 2030. (bmj.com)
  • Crohn's disease, a subtype of inflammatory bowel disease, is a disorder estimated by the US Centers for Disease Control and Prevention to afflict more than three million adult Americans. (materialstoday.com)
  • Huntington's disease (HD) is an autosomal dominant inherited disorder belonging to the group of systemic brain atrophies. (hindawi.com)
  • We developed a genetic loss-of-function screening (CRISPR-LICHT) using the cerebral organoid model which allows us to screen for genes with suspected involvement in a specific human brain disorder. (europa.eu)
  • Structural changes and neuropathology in the hypothalamus have been suggested to contribute to the non-motor manifestations of Huntington's disease (HD), a neurodegenerative disorder caused by an expanded cytosine-adenine-guanine (CAG) repeat in the huntingtin (HTT) gene. (lu.se)
  • Glutamate uptake is reduced in prefrontal cortex in Huntington's disease. (neurotree.org)
  • Rats transgenic for Huntington's disease (tgHD51 CAG rats), surviving up to two years, represent an animal model of HD similar to the late-onset form of human disease. (hindawi.com)
  • 2018). We further discovered that metabolic reprograming in neural stem cells irreversibly converts them into tumor stem cells initiating malignant overgrowth (Bonnay et al. (europa.eu)
  • Virtual Forum Summary: Do Inflammation & Metabolic Disturbances Metastasize To The Brain? (psychu.org)
  • Objective To assess reductions of cerebral glucose metabolism in Parkinson's disease (PD) with 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET), and their associations with cognitive decline. (bmj.com)
  • Dementia is loss of brain function that occurs with certain diseases. (medlineplus.gov)
  • Dementia due to metabolic causes is a loss of brain function that can occur with abnormal chemical processes in the body. (medlineplus.gov)
  • Outcome varies, depending on the cause of the dementia and the amount of damage to the brain. (medlineplus.gov)
  • Practice parameters for diagnosis and evaluation of dementia, as published by the American Academy of Neurology (AAN), consider structural brain imaging to be optimal. (medscape.com)
  • The dopamine transporter (DaTScan) is used to distinguish Lewy body dementia from Alzheimer disease. (medscape.com)
  • advanced stages of the disease include bradykinesia, rigidity, and dementia. (hindawi.com)
  • Neurodegeneration and neurodegenerative diseases (including the shared mechanisms of nerve cell death that contribute to many diseases), Vascular Cognitive Impairment and Dementia (VCID), NINDS tissue/cell resources, basic invertebrate neuromuscular junction (NMJ). (nih.gov)
  • Data from the Human Genome Project surely will be useful in identifying mutations in the thousands of genes that must underlie inherited diseases of the central and peripheral nervous system. (medscape.com)
  • Genetic data also will be useful in identifying mutations and polymorphisms that predispose to some of the acquired diseases of the nervous system, some of which are discussed in this article. (medscape.com)
  • Ceramides play a role in brain and nervous system development but are also important in maintaining healthy skin. (medicalnewstoday.com)
  • I want to talk to someone about my research proposal (basic research, neural mechanisms, or disease mechanisms). (nih.gov)
  • Brain MRI revealed bilateral and symmetrical atrophy in the fronto-temporal areas, massive enlargement of the subarachnoid spaces and hyperdensities on T (2) sequences of the basal ganglia. (nih.gov)
  • Routine structural neuroimaging evaluation has long been based on nonspecific features such as atrophy, which is a late feature in the progression of the disease. (medscape.com)
  • Brain image reveals hippocampal atrophy, especially on the right side. (medscape.com)
  • A 18 F-DOPA cerebral PET/CT, performed after injection of 72 MBq of [ 18 F]-DOPA, showed striatal dopaminergic uptake decrease (predominating in the left side) as previously described [ 3 ] (Figure 1) and a MRI demonstrated mid brain atrophy, consistent with PSP diagnosis. (omicsonline.org)
  • Researchers found low doses both improved memory performance and normalized the over-activity detected by functional magnetic resonance imaging that measures brain activity during a memory task. (sciencedaily.com)
  • Calpains are an essential protein that regulates this process, prompting researchers to investigate whether silencing calpains minimizes TBI-related brain damage. (asbmb.org)
  • By utilizing a hydrogel that absorbs body fluids, researchers have produced a brain-machine interface that doesn't trigger a foreign body response. (materialstoday.com)
  • But the availability of new techniques such as single-cell transcriptomics now enables researchers to perform increasingly detailed analyses, and will help them identify exactly which jumping genes are altered and in which regions, or cell populations, in the brain. (bigthink.com)
  • Therefore, it has been proposed that oxidative stress in the developing brains contributes to neuronal damage in genetically susceptible children, which is important in the pathophysiology of ASD. (nature.com)
  • Mitochondrial accumulation of APP was also observed in the cholinergic, dopaminergic, GABAergic, and glutamatergic neuronal types in the category III AD brains. (jneurosci.org)
  • A reduction in cerebral blood flow in brain tissue is typically accompanied by a compensatory increase in the oxygen extraction fraction (OEF) to maintain normal neuronal function. (ajnr.org)
  • Distribution and neuronal expression of phosphatidylinositol phosphate kinase IIgamma in the mouse brain. (neurotree.org)
  • A basic difference between HD pathology in human and tgHD51 rats is in the rate of NDP progression that originates primarily from slow neuronal degeneration consequently resulting in lesser extent of concomitant reactive gliosis in the brain of tgHD51 rats. (hindawi.com)
  • By the mid 1960s, defects that led to the accumulation of metabolic products in the urine, blood, or neural tissues were identified. (medscape.com)
  • Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing plaques and tau-containing neurofibrillary tangles. (medscape.com)
  • Alzheimer disease is diagnosed via clinical, neuropsychological, and neuroimaging assessments. (medscape.com)
  • Alzheimer disease was first described in 1907 by Alois Alzheimer. (medscape.com)
  • Although it was regarded as a rare disease when it was first described, Alzheimer disease has become one of the most common diseases in the aging population, ranking as the fourth most common cause of death. (medscape.com)
  • Coronal, T1-weighted magnetic resonance imaging (MRI) scan in a patient with moderate Alzheimer disease. (medscape.com)
  • MRI can be considered the preferred neuroimaging examination for Alzheimer disease because it allows accurate measurement of the 3-dimensional (3D) volume of brain structures, especially the size of the hippocampus and related regions. (medscape.com)
  • Parkinson's disease. (neurologyadvisor.com)
  • Altered vesicular dopamine storage in Parkinson's disease: a premature demise. (neurotree.org)
  • Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. (neurotree.org)
  • Tracer techniques and quantitative autoradiographic and tissue counting models for measurement of metabolic rates were combined with positron computed tomography (PCT) and (F-18)2-fluoro-2-deoxy-D-glucose (FDG) for the measurement of local cerebral metabolic rate for glucose (LCMRGlc) in humans. (nih.gov)
  • A TBI can cause brain-cell death and tissue degeneration, potentially leading to many negative clinical symptoms for the patient, depending on the severity of the injury. (asbmb.org)
  • We use a tissue culture system called cerebral organoids that we have developed in 2013 and that can recapitulate brain development at a remarkable level of detail (Lancaster et al. (europa.eu)
  • This mechanism affects the integrity of the tissue, and thus the brain size and was identified as one cause of microcephaly (Esk, Lindenhofer et al. (europa.eu)
  • Other research shows that activation of these endogenous retroviruses during normal brain development induces an inflammatory response , and that tau protein accelerates jumping gene activation in the mouse brain. (bigthink.com)
  • The current study has examined the effects of moderate maternal exposure to EtOH (10 % v/v in the drinking water) throughout gestation, or gestation and lactation, on crucial 21-day-old offspring Wistar rat brain parameters, such as the activities of acetylcholinesterase (AChE) and two adenosine triphosphatases (Na(+),K(+)-ATPase and Mg(2+)-ATPase), in major offspring CNS regions (frontal cortex, hippocampus, hypothalamus, cerebellum and pons). (gla.ac.uk)
  • New neuroimaging methods not only facilitate diagnosis of the most common neurodegenerative conditions (particularly AD) after symptom onset but also show diagnostic promise even at very early or presymptomatic phases of the disease. (medscape.com)
  • Levodopa equivalent dose, age (direct), age at disease onset (inverse), and WCST were significant predictors of FoG ( p = 0.01, p = 0.0025, p = 0.0016, and p = 0.029, respectively). (frontiersin.org)
  • The main explanatory variables of FoG occurrence are levodopa equivalent dose, age, age at disease onset, and WCST. (frontiersin.org)
  • The disease is always fatal with an average survival of 10-15 years after the onset of the first symptoms. (hindawi.com)
  • 2022). We expect to apply our knowledge on human-specific principles in brain development and pathology to other known diseases for which no therapies exist to-date. (europa.eu)
  • with chemical changes in excreta, blood, cerebrospinal fluid (CSF), and tissues, or sometimes with abnormalities found on images of the brain and other organs. (medscape.com)
  • These technological advances should improve the semiology of brain abnormalities demonstrated by 18 F-FDG PET. (omicsonline.org)
  • This enables us to follow histopathological changes in course of neurodegenerative process (NDP) within the striatum and compare them with postmortem samples of human HD brains. (hindawi.com)
  • Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease. (neurotree.org)
  • Arginine vasopressin deficiency has several causes, including a brain tumor, a brain injury, brain surgery, tuberculosis, and some forms of other diseases. (msdmanuals.com)
  • The human brain is especially vulnerable to oxidative stress because it accounts for only 2% of body mass but consumes 20% of oxygen 14 . (nature.com)
  • With the advances of magnetic resonance technology, the CBF, oxygen extraction fraction, and cerebral metabolic rate of oxygen can be measured in MRI. (ajnr.org)
  • Arterial spin-labeling and SWI sequences were used to acquire CBF, oxygen extraction fraction, and cerebral metabolic rate of oxygen. (ajnr.org)
  • Hemispheres with occluded MCA (group 3) or acute stroke (group 4) had a significantly lower CBF and cerebral metabolic rate of oxygen and a significantly higher oxygen extraction fraction than the contralateral hemisphere. (ajnr.org)
  • When this offset a decrease in CBF, the cerebral metabolic rate of oxygen remained at a normal level. (ajnr.org)
  • An occluded MCA led to reduction in both the CBF and cerebral metabolic rate of oxygen. (ajnr.org)
  • Moreover, the oxygen extraction fraction and cerebral metabolic rate of oxygen significantly increased and decreased, respectively, in the occluded MCA region during acute stroke. (ajnr.org)
  • It is possible to use both parameters and the arterial oxygen content to derive cerebral metabolic rate of oxygen (CMRO 2 ) use, which is of critical importance in the occurrence of stroke. (ajnr.org)
  • These include a lack of oxygen, rising pressure, and swelling within the brain. (rcslt.org)
  • It works to protect us from harmful substances, while allowing substances required by the brain such as water and oxygen. (yinyanghouse.com)
  • Recently, data from the Centers of Disease Control and Prevention showed that the prevalence of ASD reached 1/54 children in the United States. (nature.com)
  • Centers for Disease Control and Prevention. (cdc.gov)
  • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. (cdc.gov)
  • The Centers for Disease Control and Prevention supports this claim, citing a 17% nationwide increase in fall-related TBI deaths between 2008-2017, occurring most often in people age 75 years or older. (asbmb.org)
  • Here we report that nonglycosylated full-length and C-terminal truncated amyloid precursor protein (APP) accumulates exclusively in the protein import channels of mitochondria of human AD brains but not in age-matched controls. (jneurosci.org)
  • Furthermore, in AD brains, mitochondrially associated APP formed stable ∼480 kDa complexes with the translocase of the outer mitochondrial membrane 40 (TOM40) import channel and a super complex of ∼620 kDa with both mitochondrial TOM40 and the translocase of the inner mitochondrial membrane 23 (TIM23) import channel TIM23 in an "N in mitochondria -C out cytoplasm " orientation. (jneurosci.org)
  • AD is a genetic and sporadic neurodegenerative disease that is a common cause of cognitive impairment acquired in midlife and in late life, but its clinical impact is modified by other neurodegenerative and cerebrovascular conditions. (medscape.com)
  • This study in the Journal of Biological Chemistry identifies a toxic form of a microtubule protein, called tau, in rats' brains post-TBI. (asbmb.org)
  • There are several clinical classifications for brain injuries. (asbmb.org)
  • The impact of the osteopathic approach on chronic disease and elderly care: Proposals should explore the impact of the osteopathic approach on chronic disease and elderly care through clinical, translational or basic science research. (osteopathic.org)
  • The 19th century saw the first systemic approach to disease through the use of rational, consistent outlines for taking histories and doing physical examinations. (medscape.com)
  • If you have poor mental health symptoms or feel like your brain isn't as sharp as it used to be, you're not alone. (webmd.com)
  • Speech and language therapy intervention aims to support the recovery after a brain injury and to help the individual succeed in their environment and to enable them to participate in their community. (rcslt.org)
  • Many of these appear to code for proteins produced in the brain. (medscape.com)
  • However, drugs that clear out these proteins have little to no effect on the disease. (bigthink.com)
  • An ABI can be either a nontraumatic or a traumatic brain injury , depending on the injury's inciting source. (asbmb.org)
  • Traumatic Brain Injury (TBI) results from a trauma to the head, e.g. from a road traffic incident, assault or a fall. (rcslt.org)
  • Traumatic brain injury, also referred to as 'head injury', results from an outside force and subsequent complications which can follow and further damage the brain. (rcslt.org)
  • As a result, we now know many genetic defects responsible for neurological disease, but frequently we do not know much about the resulting protein product and therefore the pathophysiologic basis for the disease. (medscape.com)
  • [ 7 ] One of the major principles of pathophysiology that has appeared in recent decades is that many acquired diseases have one or several genetic bases (predispositions). (medscape.com)
  • Although the pathophysiology of ASD is still poorly understood, the interplay between genetic and environmental factors has been suggested to cause the disease 5 . (nature.com)
  • Genetic mutations in Lesch-Nyhan disease and its variants are heterogenous and include point mutations leading to amino acid substitution (yellow circles), point mutations leading to premature stop (red squares), insertions (blue triangles), deletions (white lines), and other more complex changes (not shown). (medscape.com)
  • Doctors refer to injuries that do not occur at or around the time of birth and are not genetic or degenerative as an acquired brain injury. (asbmb.org)
  • He has authored 20 original peer-reviewed papers relating to the use of osteopathic manipulation for pneumonia, chronic obstructive lung disease, influenza vaccine, improving immune function, applications of osteopathic philosophy, falls prevention, leg length discrepancies and, most recently, leg edema. (osteopathic.org)
  • Pathologic hallmarks of the disease include beta-amyloid (Aβ) plaques, neurofibrillary tangles (NFTs), and reactive gliosis. (medscape.com)
  • Scientists have concentrated on beta amyloid plaque buildup in the brain as the cause of this devastating disease. (thedoctorwillseeyounow.com)

No images available that match "brain diseases metabolic"